ClinicalTrials.govpublic full text
A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer
hr+ metastatic breast cancer, breast cancer, breast cancer metastatic, gmi-1359, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839876
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.